Gr-2397: review of the novel siderophore-like antifungal agent for the treatment of invasive aspergillosis

HIGHLIGHTS

• who: Karen Joy Shaw from the (UNIVERSITY) have published the Article: GR-2397: Review of the Novel Siderophore-like Antifungal Agent for the Treatment of Invasive Aspergillosis, in the Journal: (JOURNAL) of 14/08/2012
• how: This first-in-human randomized double-blind placebo-controlled doseescalation study was conducted in healthy adults to assess the safety tolerability and pharmacokinetics of single- and multiple-ascending intravenous doses .
• future: Studies are necessary to differentiate these or other possibilities. Studies are necessary to assess whether or not sit1 mutants will arise clinically in different species and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.